Paula Raposinho - Concepedia

Author

Paula Raposinho

Also Known As

Ana Belchior, P D Raposinho, P. D. Raposinho, P. Raposinho, P.D. Raposinho, Paula D Raposinho, Paula D. Raposinho, Paula Raposinho, Paula. D. Raposinho, Raposinho, P.

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

University of Lisbon University of Geneva University of Zurich TARH (Portugal)Instituto Superior Técnico

About

Paula Raposinho is an author at University of Lisbon specializing in pharmacology, medicine, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	591
2	Natural Sciences	8	8	162
3	Engineering	4	4	103
4	Health Sciences	1	1	143
5	Social Sciences	1	1	51

Paula Raposinho

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Chronic administration of neuropeptide Y into the lateral ventricle of C57BL/6J male mice produces an obesity syndrome including hyperphagia, hyperleptinemia, insulin resistance, and hypogonadism Paula Raposinho, D. D. Pierroz, Pierre Broqua, Molecular and Cellular Endocrinology Obesity SyndromeChronic AdministrationGastrointestinal Peptide HormoneObesityMetabolic Syndrome	2001	143
[(Cp‐R)M(CO)<sub>3</sub>] (M=Re or <sup>99m</sup>Tc) Arylsulfonamide, Arylsulfamide, and Arylsulfamate Conjugates for Selective Targeting of Human Carbonic Anhydrase IX Daniel Can, Bernhard Spingler, Paul Schmutz, Angewandte Chemie International Edition	2012	121
Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor Subtype1 Paula Raposinho, Pierre Broqua, Dominique D. Pierroz, Endocrinology	1999	106
Evaluation of Acridine Orange Derivatives as DNA-Targeted Radiopharmaceuticals for Auger Therapy: Influence of the Radionuclide and Distance to DNA E. Pereira, Letícia Quental, Elisa Palma, Scientific Reports	2017	69
Nuclear Targeting with an Auger Electron Emitter Potentiates the Action of a Widely Used Antineoplastic Drug S. Imstepf, Vanessa Pierroz, Paula Raposinho, Bioconjugate Chemistry PharmacotherapyHomologous Rhenium ConjugateOncologyAuger RadiationRadiopharmaceutical Therapy	2015	55
Chronic Blockade of the Melanocortin 4 Receptor Subtype Leads to Obesity Independently of Neuropeptide Y Action, with No Adverse Effects on the Gonadotropic and Somatotropic Axes**This work was supported by grants from the Swiss National Research Science Foundation (31–39729-93, 31–55732-98, and 32–04912 3–97) and in part by Ferring Pharmaceuticals Ltd. Research Laboratories. Paula Raposinho, Einar Castillo, Violaine d’Allèves, Endocrinology	2000	54
Chronic Neuropeptide Y Infusion into the Lateral Ventricle Induces Sustained Feeding and Obesity in Mice Lacking Either Npy1r or Npy5r Expression Paula Raposinho, Thierry Pedrazzini, Richard White, Endocrinology Food IntakeSocial SciencesGastrointestinal Peptide HormoneObesityMetabolic Syndrome	2003	51
A 99mTc(CO)3-labeled pyrazolyl–α-melanocyte-stimulating hormone analog conjugate for melanoma targeting Paula Raposinho, João D. G. Correia, Susana Alves, Nuclear Medicine and Biology Drug TargetingMedicineMelanomaTumor TargetingPharmacology	2007	50
Melanoma targeting with α-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties Paula Raposinho, Catarina Xavier, João D. G. Correia, JBIC Journal of Biological Inorganic Chemistry Drug TargetingTumor-seeking PropertiesMedicineMelanomaPharmacology	2008	49
The Melanocortin Agonist Melanotan‐II Reduces the Orexigenic and Adipogenic Effects of Neuropeptide Y (NPY) but Does not Affect the NPY‐Driven Suppressive Effects on the Gonadotropic and Somatotropic Axes in the Male Rat Paula Raposinho, R.B. White, Martine Aubert Journal of Neuroendocrinology	2003	48

Page 1